Biostasis
ArchivedDARPA - Biological Technologies Office
Description
DARPA seeks novel approaches to reversibly pause and/or slow the functions and preserve viability of living cells without reliance on cold temperature. This new technology aims to directly address needs within the Department of Defense to maintain and deliver biological therapeutics and extend the window of time for effective use of field forward therapeutics. See the HR001118S0034 document attached.
Who can apply
- Unrestricted
Contact
DARPA/BTO <br/>ATTN: HR001118S0034 <br/>675 North Randolph Street <br/>Arlington, VA 22203-2114
Biostasis@darpa.mil
- PostedMar 16, 2018
- ClosesMay 22, 2018
- CFDA12.910
Get more from this grant
Edit and export this grant’s proposal template, plus deadline reminders, similar-grant suggestions, and funder history — available free when you're signed in.
Sign in to use tools